Buscar
01/03/2022
Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists
de Santiago, ER, Aldehuelo, RS, Pons, FR, Escaja, CR, Fernandez-Esparrach, G, Canete-Ruiz, A, Aracil, CF, Perez-Corte, D, Leon, RR, Marcos-Prieto, HM, Delgado-Guillena, PG, Garcia-Rodriguez, A, Guarner-Argente, C, Muriel, A, de la Fuente-Briongos, E, de Paredes, AGG, Parejo-Carbonell, S, Tellez, L, Senosiain-Lalastra, C, Burgos-Santamaria, D, Aicart-Ramos, M, Munoz, BM, Penas-Garcia, B, Pagano, G, Urquiza, GC, Ferreruela, MU, de Jorge-Turrion, MA, Barreiro-Alonso, E, Fraile-Lopez, M, Gomez-Outomuro, A, Altamirano, MI, Esteban, MN, Ruiz-Andreu, M, Arribas-Anta, J, de Frutos, D, Herreros-de-Tejada, A, Arias-Rivera, ML, Roldan-Fernandez, M, Martin, AFM, Zamora, J, Vazquez-Sequeiros, E, Albillos, A. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists. Clinical Gastroenterology and Hepatology. 2022; 20(3)DOI:10.1016/j.cgh.2020.11.037. PMID:33279783. IF:12.600(Q1/1D).
01/03/2022
Epidemiology of Echovirus 30 Infections Detected in a University Hospital in Catalonia, Spain, in 1995-2020
del Cuerpo, M, de Audicana, JG, Fernandez-Garcia, MD, Marin, P, Esteban, M, Espanol, M, Cabrerizo, M, Rabella, N. Epidemiology of Echovirus 30 Infections Detected in a University Hospital in Catalonia, Spain, in 1995-2020. Microorganisms. 2022; 10(3)DOI:10.3390/microorganisms10030592. PMID:35336167. IF:4.500(Q2/4D).
01/03/2022
Tetracycline resistance transmission in Campylobacter is promoted at temperatures resembling the avian reservoir (vol 244, 108652, 2020)
Cuevas-Ferrando, E, Guirado, P, Miro, E, Iglesias-Torrens, Y, Navarro, F, Alioto, TS, Gomez-Garrido, J, Madrid, C, Balsalobre, C. Tetracycline resistance transmission in Campylobacter is promoted at temperatures resembling the avian reservoir (vol 244, 108652, 2020). VETERINARY MICROBIOLOGY. 2022; 266DOI:10.1016/j.vetmic.2022.109368. PMID:35216838. IF:3.300(Q1/1D).
01/03/2022
Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists
Alvarado, PM, de Oro, JJD, Espinar, MA, Perez, EA, Perez, NB, Carmona, L, Burgos, EC, Poch, TC, Aguilera, AC, Mendieta, ED, Alarcon, PE, Casares, EG, Perez, SH, Lopez, BM, Morillo, MM, Soria, LM, Pastor, CM, Martinez-Losa, MM, Fernandez, AP, Busquets, MP, Garcia, JR, Sanz, DR, Lizarzaburu, MS, Santo Panero, P, Alierta, ES, Roc, MV, Macias, HC. Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists. RHEUMATOLOGY INTERNATIONAL. 2022; 42(3)DOI:10.1007/s00296-020-04733-y. PMID:33146762. IF:4.000(Q2/5D).
01/03/2022
Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension
Sapina-Beltran, E, Benitez, ID, Torres, G, Fortuna-Gutierrez, AM, Marquez, PP, Masa, JF, Drager, LF, Cabrini, M, Felez, M, Vazquez, S, Abad, J, Lee, C, Garcia-Rio, F, Casitas, R, Mediano, O, Peralta, SR, Martinez, D, Sanchez-de-la-Torre, M, Barbe, F, Dalmases, M. Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension. HYPERTENSION RESEARCH. 2022; 45(3)DOI:10.1038/s41440-021-00762-7. PMID:34952953. IF:5.400(Q2/3D).
01/03/2022
Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort
Baptista-Serna L., Rodrigo-Muñoz J.M., Mínguez P., Valverde-Monge M., Arismendi E., Barranco P., Barroso B., Bobolea I., Cañas J.A., Cárdaba B., Cruz M.J., Curto E., Domínguez-Ortega J., García-Latorre R., González-Barcala F.J., Martínez-Rivera C., Mullol J., Muñoz X., Olaguibel J.M., Picado C., Plaza V., Quirce S., Rial M.J., Sastre B., Soto L., Valero A., del Pozo V., Sastre J.. Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort. Journal of Allergy and Clinical Immunology-In Practice. 2022; 10(3)DOI:10.1016/j.jaip.2021.10.013. PMID:34673289. IF:9.400(Q1/2D).
01/03/2022
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
Agusti, A, De Stefano, G, Levi, A, Munoz, X, Romero-Mesones, C, Sibila, O, Lopez-Giraldo, A, Moral, VP, Curto, E, Echazarreta, AL, Marquez, SE, Pascual-Guardia, S, Santos, S, Marin, A, Valdes, L, Saldarini, F, Salgado, C, Casanovas, G, Varea, S, Rios, J, Faner, R. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2022; 59(3)DOI:10.1183/13993003.03036-2021. PMID:35144989. IF:24.300(Q1/1D).
01/03/2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Podzamczer, D, Mican, R, Tiraboschi, J, Portilla, J, Domingo, P, Llibre, JM, Ribera, E, Vivancos, MJ, Morano, L, Masia, M, Gomez, C, Fanjul, F, Payeras, A, Inciarte, A, Estrada, V, Rivero, A, Castro, A, Bernal, E, Vinuesa, D, Knobel, H, Troya, J, Macias, J, Montero, M, Sanz, J, Navarro-Alcaraz, A, Caicedo, A, Fernandez, G, Martinez, E, Moreno, S. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3)DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4.200(Q2/4D).
01/03/2022
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
Garcia-Alfonso, P, Saiz-Rodriguez, M, Mondejar, R, Salazar, J, Paez, D, Borobia, AM, Safont, MJ, Garcia-Garcia, I, Colomer, R, Garcia-Gonzalez, X, Herrero, MJ, Lopez-Fernandez, LA, Abad-Santos, F. Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines. Clinical & Translational Oncology. 2022; 24(3)DOI:10.1007/s12094-021-02708-4. PMID:34773566. IF:3.400(Q3/6D).
01/03/2022
PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence
Eggermont, AMM, Ascierto, PA, Khushalani, NI, Schadendorf, D, Boland, G, Weber, J, Lewis, KD, Johnson, D, Rivalland, G, Khattak, A, Majem, M, Gogas, H, Long, GV, Currie, SL, Chien, D, Tagliaferri, MA, Carlino, MS, Diab, A. PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence. Future Oncology. 2022; 18(8)DOI:10.2217/fon-2021-1286. PMID:35073733. IF:3.300(Q3/6D).
01/03/2022
Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome
Sanchez, A, Roos, VH, Navarro, M, Pineda, M, Caballol, B, Moreno, L, Carballal, S, Rodriguez-Alonso, L, Cajal, TRY, Llort, G, Pinol, V, Lopez-Fernandez, A, Salces, I, Pico, MD, Rivas, L, Bujanda, L, Garzon, M, Pizarro, A, de Castro, EM, Lopez-Arias, MJ, Poves, C, Garau, C, Rodriguez-Alcalde, D, Herraiz, M, Alvarez-Urrutia, C, Dacal, A, Carrillo-Palau, M, Cid, L, Ponce, M, Barreiro-Alonso, E, Saperas, E, Aguirre, E, Romero, C, Bastiaansen, B, Gonzalez-Acosta, M, Morales-Romero, B, Ocana, T, Rivero-Sanchez, L, Jung, G, Bessa, X, Cubiella, J, Jover, R, Rodriguez-Moranta, F, Balmana, J, Brunet, J, Castells, A, Dekker, E, Capella, G, Serra-Burriel, M, Moreira, L, Pellise, M, Balaguer, F. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clinical Gastroenterology and Hepatology. 2022; 20(3)DOI:10.1016/j.cgh.2020.11.002. PMID:33157315. IF:12.600(Q1/1D).
01/03/2022
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
Wu, YL, John, T, Grohe, C, Majem, M, Goldman, JW, Kim, SW, Kato, T, Laktionov, K, Vu, HV, Wang, ZJ, Lu, S, Lee, KY, Akewanlop, C, Yu, CJ, de Marinis, F, Bonanno, L, Domine, M, Shepherd, FA, Zeng, LM, Atasoy, A, Herbst, RS, Tsuboi, M. Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC. Journal of Thoracic Oncology. 2022; 17(3)DOI:10.1016/j.jtho.2021.10.014. PMID:34740861. IF:20.400(Q1/1D).
01/03/2022
The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
Sanchez, JM, Carratala, JV, Serna, N, Unzueta, U, Nolan, V, Sanchez-Chardi, A, Volta-Duran, E, Lopez-Laguna, H, Ferrer-Miralles, N, Villaverde, A, Vazquez, E. The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies. Pharmaceutics. 2022; 14(3)DOI:10.3390/pharmaceutics14030602. PMID:35335976. IF:5.400(Q1/2D).
01/03/2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Hernandez-Boluda, JC, Pereira, A, Zinger, N, Gras, L, Martino, R, Paneesha, S, Finke, J, Chinea, A, Rambaldi, A, Robin, M, Saccardi, R, Natale, A, Snowden, JA, Tsirigotis, P, Vallejo, C, Wulf, G, Xicoy, B, Russo, D, Maertens, J, Daguindau, E, Lenhoff, S, Hayden, P, Czerw, T, McLornan, DP, Yakoub-Agha, I. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. BONE MARROW TRANSPLANTATION. 2022; 57(3)DOI:10.1038/s41409-021-01553-x. PMID:35066569. IF:4.800(Q1/2D).
01/03/2022
Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery
Serna, N, Pallares, V, Unzueta, U, Garcia-Leon, A, Volta-Duran, E, Sanchez-Chardi, A, Parlade, E, Rueda, A, Casanova, I, Falgas, A, Alba-Castellon, L, Sierra, J, Villaverde, A, Vazquez, E, Mangues, R. Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery. JOURNAL OF CONTROLLED RELEASE. 2022; 343DOI:10.1016/j.jconrel.2022.01.017. PMID:35051493. IF:10.800(Q1/1D).
01/03/2022
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
Ramos-Campoy, S, Puiggros, A, Bea, S, Bougeon, S, Larrayoz, MJ, Costa, D, Parker, H, Rigolin, GM, Ortega, M, Blanco, ML, Collado, R, Salgado, R, Baumann, T, Gimeno, E, Moreno, C, Bosch, F, Calvo, X, Calasanz, MJ, Cuneo, A, Strefford, JC, Nguyen-Khac, F, Oscier, D, Haferlach, C, Schoumans, J, Espinet, B. Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients. HAEMATOLOGICA. 2022; 107(3)DOI:10.3324/haematol.2020.274456. PMID:33691382. IF:10.100(Q1/2D).
01/03/2022
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke The CHOICE Randomized Clinical Trial
Renu, A, Millan, M, San Roman, L, Blasco, J, Marti-Fabregas, J, Terceno, M, Amaro, S, Serena, J, Urra, X, Laredo, C, Barranco, R, Camps-Renom, P, Zarco, F, Oleaga, L, Cardona, P, Castano, C, Macho, J, Cuadrado-Godia, E, Vivas, E, Lopez-Rueda, A, Guimaraens, L, Ramos-Pachon, A, Roquer, J, Muchada, M, Tomasello, A, Davalos, A, Torres, F, Chamorro, A. Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke The CHOICE Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2022; 327(9)DOI:10.1001/jama.2022.1645. PMID:35143603. IF:120.700(Q1/1D).
01/03/2022
Predictors of Functional Outcome After Thrombectomy in Patients With Prestroke Disability in Clinical Practice
Millán M, Ramos-Pachón A, Dorado L, Bustamante A, Hernández-Pérez M, Rodríguez-Esparragoza L, Gomis M, Remollo S, Castaño C, Werner M, Wenger D, Rubio S, Domínguez-Lizarbe M, Terceño M, Paipa AJ, Rodríguez-Vázquez A, Boned S, Camps-Renom P, Cánovas D, Giralt E, López-Cancio E, Dávalos A, Ros-Roig J, Pérez de la Ossa N. Predictors of Functional Outcome After Thrombectomy in Patients With Prestroke Disability in Clinical Practice. STROKE. 2022; 53(3)DOI:10.1161/STROKEAHA.121.034960. PMID:34702065. IF:8.300(Q1/1D).
01/03/2022
International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery
Lindgren, AG, Braun, RG, Majersik, JJ, Clatworthy, P, Mainali, S, Derdeyn, CP, Maguire, J, Jern, C, Rosand, J, Cole, JW, Lee, JM, Khatri, P, Nyquist, P, Debette, S, Wei, LK, Rundek, T, Leifer, D, Thijs, V, Lemmens, R, Heitsch, L, Prasad, K, Conde, JJ, Dichgans, M, Rost, NS, Cramer, SC, Bernhardt, J, Worrall, BB, Fernandez-Cadenas, I. International stroke genetics consortium recommendations for studies of genetics of stroke outcome and recovery. International Journal of Stroke. 2022; 17(3)DOI:10.1177/17474930211007288. PMID:33739214. IF:6.700(Q1/2D).
25/02/2022
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study
Aapkes, SE, Bernts, LHP, van den Berg, AP, van den Berg, M, Blokzijl, H, Cantineau, AEP, van Gastel, MDA, de Haas, RJ, Kappert, P, Muller, RU, Nevens, F, Torra, R, Visser, A, Drenth, JPH, Gansevoort, RT. Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study. BMC GASTROENTEROLOGY. 2022; 22(1)DOI:10.1186/s12876-022-02142-y. PMID:35216547. IF:2.400(Q4/9D).
24/02/2022
Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021)
Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Sevilla-Llewellyn-Jones, J, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Ochoa, S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021). SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-021-00199-4. PMID:35210466. IF:5.400(Q2/3D).
23/02/2022
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Pinana, JL, Vazquez, L, Martino, R, de la Camara, R, Sureda, A, Rodriguez-Veiga, R, Garrido, A, Sierra, J, Ribera, JM, Torrent, A, Mateos, MV, de la Rubia, J, Tormo, M, Diez-Campelo, M, Garcia-Gutierrez, V, Alvarez-Larran, A, Sancho, JM, MartinGarcia-Sancho, A, Yanez, L, Simon, JAP, Barba, P, Abrisqueta, P, Alvarez-Twose, I, Bonanad, S, Lecumberri, R, Ruiz-Camps, I, Navarro, D, Hernandez-Rivas, JA, Cedillo, A, Garcia-Sanz, R, Bosch, F. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. LEUKEMIA & LYMPHOMA. 2022; 63(3)DOI:10.1080/10428194.2021.1992619. PMID:34668835. IF:2.600(Q3/7D).
22/02/2022
The ERA Registry Annual Report 2019: summary and age comparisons
Boenink, R, Astley, ME, Huijben, JA, Stel, VS, Kerschbaum, J, Ots-Rosenberg, M, Asberg, AA, Lopot, F, Golan, E, de la Nuez, PC, Camblor, MR, Trujillo-Aleman, S, San Millan, JCR, Mingo, PU, Diaz, JM, Bouzas-Caamano, ME, Artamendi, M, Madre, MA, de Pablos, CS, Roblero, MFS, Zurriaga, O, Stendahl, ME, Bell, S, Idrizi, A, Ioannou, K, Debska-Slizien, A, Galvao, AA, De Meester, JM, Resic, H, Hommel, K, Radunovic, D, Palsson, R, Lassalle, M, Finne, P, Bazaga, MD, Gjorgjievski, N, Seyahi, N, Bonthuis, M, Ortiz, A, Jager, KJ, Kramer, A. The ERA Registry Annual Report 2019: summary and age comparisons. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab273. PMID:35211303. IF:4.600(Q1/2D).
22/02/2022
CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome
Roca, N, Jatem, E, Abo, A, Santacana, M, Cruz, A, Madrid, A, Fraga, G, Martin, M, Gonzalez, J, Martinez, C, Balius, A, Segarra, A. CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab215. PMID:35211308. IF:4.600(Q1/2D).
22/02/2022
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
Bataller, A, Garrido, A, Guijarro, F, Onate, G, Diaz-Beya, M, Arnan, M, Tormo, M, Vives, S, de Llano, MPQ, Coll, R, Gallardo, D, Vall-Llovera, F, Escoda, L, Garcia-Guinon, A, Salamero, O, Sampol, A, Merchan, BM, Bargay, J, Castano-Diez, S, Esteban, D, Oliver-Caldes, A, Rivero, A, Mozas, P, Lopez-Guerra, M, Pratcorona, M, Zamora, L, Costa, D, Rozman, M, Nomdedeu, JF, Colomer, D, Brunet, S, Sierra, J, Esteve, J. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood Advances. 2022; 6(4)DOI:10.1182/bloodadvances.2021005585. PMID:34911079. IF:7.500(Q1/2D).
21/02/2022
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus
Stocchi, F, Antonini, A, Berg, D, Bergmans, B, Jost, W, Katzenschlager, R, Kulisevsky, J, Odin, P, Valldeoriola, F, Chaudhuri, KR. Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus. npj Parkinsons Disease. 2022; 8(1)DOI:10.1038/s41531-022-00277-z. PMID:35190544. IF:8.700(Q1/1D).
19/02/2022
Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area
Malmusi, D, Pasarin, MI, Mari-Dell'Olmo, M, Artazcoz, L, Diez, E, Tolosa, S, Rodriguez-Sanz, M, Perez, G, Pena-Gallardo, C, Borrell, C. Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area. International Journal for Equity in Health. 2022; 21(1)DOI:10.1186/s12939-022-01628-1. PMID:35183189. IF:4.800(Q1/2D).
18/02/2022
Endothelium-Released Microvesicles Transport miR-126 That Induces Proangiogenic Reprogramming in Monocytes
Arderiu, G, Pena, E, Civit-Urgell, A, Badimon, L. Endothelium-Released Microvesicles Transport miR-126 That Induces Proangiogenic Reprogramming in Monocytes. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.836662. PMID:35251029. IF:7.300(Q1/3D).
17/02/2022
Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity
Garcia-Beltran, C, Cereijo, R, Plou, C, Gavalda-Navarro, A, Malpique, R, Villarroya, J, Lopez-Bermejo, A, de Zegher, F, Ibanez, L, Villarroya, F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3)DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5.800(Q1/3D).
16/02/2022
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients
Masana, L, Correig, E, Rodriguez-Borjabad, C, Anoro, E, Arroyo, JA, Jerico, C, Pedragosa, A, la Miret, M, Naf, S, Pardo, A, Perea, V, Perez-Bernalte, R, Plana, N, Ramirez-Montesinos, R, Royuela, M, Soler, C, Urquizu-Padilla, M, Zamora, A, Pedro-Botet, J. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2)DOI:10.1093/ehjcvp/pvaa128. PMID:33135047. IF:7.100(Q1/1D).
15/02/2022
A Score to Assess Mortality After Percutaneous Mitral Valve Repair
Raposeiras-Roubin, S, Adamo, M, Freixa, X, Arzamendi, D, Benito-Gonzalez, T, Montefusco, A, Pascual, I, Nombela-Franco, L, Rodes-Cabau, J, Shuvy, M, Portoles-Hernandez, A, Godino, C, Caneiro-Queija, B, Lupi, L, Regueiro, A, Li, CH, Fernandez-Vazquez, F, Frea, S, Avanzas, P, Tirado-Conte, G, Paradis, JM, Peretz, A, Monivas, V, Baz, JA, Galasso, M, Branca, L, Sanchis, L, Asmarats, L, Garrote-Coloma, C, Angelini, F, Leon, V, Pozo, E, Alperi, A, Beeri, R, Cani, D, Sabate, M, Fernandez-Peregrina, E, Gualis, J, Bocchino, PP, Curello, S, Abu-Assi, E, Iniguez-Romo, A, Bedogni, F, Rubbio, AP, Testa, L, Grasso, C, Estevez-Loureiro, R. A Score to Assess Mortality After Percutaneous Mitral Valve Repair. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022; 79(6)DOI:10.1016/j.jacc.2021.11.041. PMID:35144748. IF:24.000(Q1/1D).
14/02/2022
Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View
Lee-Rueckert, M, Lappalainen, J, Kovanen, PT, Escola-Gil, JC. Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.777822. PMID:35237673. IF:3.600(Q2/5D).
09/02/2022
Cortical microstructure in primary progressive aphasia: a multicenter study
Illan-Gala, I, Montal, V, Borrego-Ecija, S, Mandelli, ML, Falgas, N, Welch, AE, Pegueroles, J, Santos-Santos, M, Bejanin, A, Alcolea, D, Dols-Icardo, O, Belbin, O, Sanchez-Saudinos, MB, Bargallo, N, Gonzalez-Ortiz, S, Llado, A, Blesa, R, Dickerson, BC, Rosen, HJ, Miller, BL, Lleo, A, Gorno-Tempini, ML, Sanchez-Valle, R, Fortea, J. Cortical microstructure in primary progressive aphasia: a multicenter study. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00974-0. PMID:35139897. IF:9.000(Q1/1D).
09/02/2022
Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population
Cebrian-Cuenca, AM, Mata-Cases, M, Franch-Nadal, J, Mauricio, D, Orozco-Beltran, D, Consuegra-Sanchez, L. Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population. European Journal of Preventive Cardiology. 2022; 28(18)DOI:10.1093/eurjpc/zwaa073. PMID:33733654. IF:8.300(Q1/2D).
09/02/2022
Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial
van Poppel, MNM, Corcoy, R, Hill, D, Simmons, D, Mendizabal, L, Zulueta, M, Simon, L, Desoye, G, Perez, JMA, Kautzky-Willer, A, Harreiter, J, Damm, P, Mathiesen, E, Jensen, DM, Andersen, LLT, Dunne, F, Lapolla, A, Dalfra, MG, Bertolotto, A, van Poppel, M, Jelsma, JGM, Snoek, FJ, Galjaard, S, Wender-Ozegowska, E, Zawiejska, A, Devlieger, R, DALI Core Investigator Grp. Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial. AMERICAN JOURNAL OF CLINICAL NUTRITION. 2022; 115(2)DOI:10.1093/ajcn/nqab347. PMID:34669935. IF:7.100(Q1/2D).
08/02/2022
Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
Hughes, DA, Aguiar, P, Lidove, O, Nicholls, K, Nowak, A, Thomas, M, Torra, R, Vujkovac, B, West, ML, Feriozzi, S. Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?. Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02181-4. PMID:35135579. IF:3.700(Q2/4D).
08/02/2022
Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study
Wendel-Garcia, PD, Mas, A, Gonzalez-Isern, C, Ferrer, R, Manez, R, Masclans, JR, Sandoval, E, Vera, P, Trenado, J, Fernandez, R, Sirvent, JM, Martinez, M, Ibarz, M, Garro, P, Lopera, JL, Bodi, M, Yebenes-Reyes, JC, Triginer, C, Vallverdu, I, Baro, A, Bodi, F, Saludes, P, Valencia, M, Roche-Campo, F, Huerta, A, Cambra, FJ, Barbera, C, Echevarria, J, Penuelas, O, Mancebo, J, UCIsCAT Study Grp. Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study. CRITICAL CARE. 2022; 26(1)DOI:10.1186/s13054-022-03905-5. PMID:35135588. IF:15.100(Q1/2D).
08/02/2022
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19
Pinana, JL, Garcia-Sanz, R, Martino, R, Garcia-Rao, M, Martin-Martin, GA, Risco-Galvez, I, Tormo, M, Martinez-Barranco, P, Marcos-Corrales, S, Calabuig, M, Conesa, V, Teruel, A, Ruiz-Perez, S, Solano, C, Navarro, D, Cedillo, A, Sureda, A. Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19. Blood Advances. 2022; 6(3)DOI:10.1182/bloodadvances.2021006326. PMID:34905620. IF:7.500(Q1/2D).
08/02/2022
Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1
Onate, G, Bataller, A, Garrido, A, Hoyos, M, Arnan, M, Vives, S, Coll, R, Tormo, M, Sampol, A, Escoda, L, Salamero, O, Garcia, A, Bargay, J, Aljarilla, A, Nomdedeu, JF, Esteve, J, Sierra, J, Pratcorona, M. Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Advances. 2022; 6(3)DOI:10.1182/bloodadvances.2020004136. PMID:34516636. IF:7.500(Q1/2D).
08/02/2022
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
Menghrajani, K, Gomez-Arteaga, A, Madero-Marroquin, R, Zhang, MJ, Bo-Subait, K, Sanchez, J, Wang, HL, Aljurf, M, Assal, A, Bacher, VU, Badawy, SM, Bejanyan, N, Bhatt, VR, Bredeson, C, Byrne, M, Castillo, P, Cerny, J, Chhabra, S, Ciurea, SO, DeFilipp, Z, Farhadfar, N, Gadalla, S, Gale, RP, Ganguly, S, Gowda, L, Grunwald, MR, Hashmi, S, Hildebrandt, G, Kanakry, CG, Kansagra, A, Khimani, F, Krem, M, Lazarus, H, Liu, HT, Martino, R, Michelis, FV, Nathan, S, Nishihori, T, Olsson, R, Reshef, R, Rizzieri, D, Rowe, JM, Savani, BN, Seo, S, Sharma, A, Solh, M, Ustun, C, Verdonck, LF, Hourigan, C, Sandmaier, B, Litzow, M, Kebriaei, P, Weisdorf, D, Zhang, YM, Tallman, MS, Saber, W. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances. 2022; 6(3)DOI:10.1182/bloodadvances.2021004881. PMID:34551064. IF:7.500(Q1/2D).